Xiaofeng Zheng

6PUBLICATIONS
62CO-AUTHORS
Liquid biopsiesMolecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 19, 2025
Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131).

Mohamed A Gouda, Filip Janku, Ying Yuan

|Apr 29, 2025
Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.

Kaushik Varadarajan, Christian X Cruz Pico, Kurt W Evans

|Nov 25, 2024
Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models.

Funda Meric-Bernstam, Erkan Yuca, Kurt W Evans

|Nov 08, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer.

Timothy P DiPeri, Kurt W Evans, Stephen Scott

|Feb 15, 2024
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.

Timothy P DiPeri, Kurt W Evans, Bailiang Wang

|Jun 06, 2023
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.

Timothy P DiPeri, Kurt W Evans, Maria Gabriela Raso

Pageof 1